
Banning Industry From FDA Adcomms Won’t ‘Move the Needle Much’ in Makary, RFK’s Fight Against COIs
Newly confirmed FDA commissioner Marty Makary wants to “restore impeccable integrity” to the drug review process, and he’s starting by banning pharmaceutical representatives from serving as members on some of the agency’s advisory committees. Reaction to …